Does anyone know if dialysis would clear the blood of this stuff?
good question...
Spike proteins are twisted protein pieces basically like prions. You can’t get rid of this stuff through dialysis.
They can replace the standard dialysis filters with one that can trap cytokines, for example, so it may be possible. ...Although the procedure of dialysis carries an increased risk of infection and other risks so you might not want to do that. Better to try some other intervention that reduces the mischief the spike proteins are causing.
“ Does anyone know if dialysis would clear the blood of this stuff?”
Unlikely.
The protein is made the the mRNA which is probably retained in cells.
But, you never know until done.
In Sweden there were lab studies done in vetro that showed it was possible for a body mechanism to reverse transcribe the mRNA fragment and change the DNA.
The “Experts” deny this is possible, but they have been consistently wrong about everything. Why should this be any different?
It is unknown at this point if anything can remove what was injected and the things the body does with it.
A recent laboratory study in Sweden indicates that the Pfizer- BioNtech COVID-19 vaccine is able to enter a human liver cell line where it is reverse transcribed into DNA within a matter of hours. As a result, the possibility that the COVID-19 vaccines affect DNA cannot be ruled out.
https://rwmalonemd.substack.com/p/covid-19-vaccines-and-informed-consent
My web search of myocarditis 2021 vs 2023 NOW gives dialysis as one of the treatments of myocarditis.
Make of a it as you will.
Do they now know what they are trying too correct?
It’s poison, I tell ya!
According to the Japanese, nattokinase will.
Nattokinase is the active ingredient (responsible for breaking down blood clots) of natto, which is a fermented soybean dish many Japanese eat for breakfast. It was discovered after researchers noticed the Japanese had fewer heart attacks than expected given how much they smoked.
Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2
by Takashi Tanikawa 1,*,†,Yuka Kiba 2,†,James Yu 3,Kate Hsu 3,Shinder Chen 3,Ayako Ishii 4,Takami Yokogawa 2ORCID,Ryuichiro Suzuki 5,Yutaka Inoue 1ORCID andMasashi Kitamura 2,*
Abstract
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as a pandemic and has inflicted enormous damage on the lives of the people and economy of many countries worldwide. However, therapeutic agents against SARS-CoV-2 remain unclear. SARS-CoV-2 has a spike protein (S protein), and cleavage of the S protein is essential for viral entry. Nattokinase is produced by Bacillus subtilis var. natto and is beneficial to human health. In this study, we examined the effect of nattokinase on the S protein of SARS-CoV-2. When cell lysates transfected with S protein were incubated with nattokinase, the S protein was degraded in a dose- and time-dependent manner. Immunofluorescence analysis showed that S protein on the cell surface was degraded when nattokinase was added to the culture medium. Thus, our findings suggest that nattokinase exhibits potential for the inhibition of SARS-CoV-2 infection via S protein degradation.
https://www.mdpi.com/1420-3049/27/17/5405